CALA - Calithera Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-86,187
-54,629
-27,826
-38,004
-32,644
Depreciation & amortization
507
505
365
297
404
Deferred income taxes
-
-
-
-
-
Stock based compensation
7,114
7,437
5,536
4,250
3,272
Change in working capital
7,497
-17,883
35,221
1,842
-1,404
Accounts receivable
771
-855
-1,142
-
-
Inventory
-
-
-
-
-
Accounts Payable
229
175
674
-28
-131
Other working capital
-71,276
-65,056
12,522
-31,426
-30,374
Other non-cash items
-
-
-
4,840
3,718
Net cash provided by operating activites
-71,124
-64,842
13,751
-31,025
-29,933
Cash flows from investing activities
Investments in property, plant and equipment
-
-214
-1,229
-401
-441
Acquisitions, net
-
-
-
-
-
Purchases of investments
-85,788
-76,107
-194,650
-44,618
-109,099
Sales/Maturities of investments
106,750
129,120
97,448
68,724
42,764
Other investing activites
-
-
-394
0
0
Net cash used for investing activites
20,810
52,799
-98,825
23,705
-66,776
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
70,249
13,705
121,615
11,281
-
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
-
0
0
Net cash used privided by (used for) financing activities
71,236
14,626
122,948
11,816
845
Net change in cash
20,922
2,583
37,874
4,496
-95,864
Cash at beginning of period
56,310
48,915
10,601
6,105
101,969
Cash at end of period
77,232
51,498
48,475
10,601
6,105
Free Cash Flow
Operating Cash Flow
-71,124
-64,842
13,751
-31,025
-29,933
Capital Expenditure
-
-214
-1,229
-401
-441
Free Cash Flow
-71,276
-65,056
12,522
-31,426
-30,374